Search Results - "Allegretta, L."

Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study by Tursi, A, Mocci, G, Cuomo, A, Allegretta, L, Aragona, G, Colucci, R, Della Valle, N, Ferronato, A, Forti, G, Gaiani, F, Graziani, M G, Lorenzetti, R, Luzza, F, Paese, P, Penna, A, Pica, R, Piergallini, S, Pranzo, G, Rodino, S, Scarcelli, A, Zampaletta, C, Cicerone, C, Cocco, A, De' Angelis, G, Donnarumma, L, Franceschi, M, Gallina, S, Grasso, G, Larussa, T, Luppino, I, Faggiani, R, Fanigliulo, L, Pagnini, C, Perazzo, P, Sacco, R, Sebkova, L, Scorza, S, Serio, M, De Monti, A, Picchio, M, Elisei, W, Maconi, G

“…Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in…”
Get more information

P.11.20: Real-Life Prospective Experience with Adalimumab in Inducing Remission in Ulcerative Colitis in Primary Inflammatory Bowel Diseases Centres by Tursi, A, Allegretta, L, Della Valle, N, Elisei, W, Forti, G, Faggiani, R, Lorenzetti, R, Mocci, G, Penna, A, Pranzo, G, Paiano, P, Ricciardelli, C, Zampaletta, C, Picchio, M

Get full text

P544 Ustekinumab safety and effectiveness in ulcerative colitis patients: results from a large real-life study by Mocci, G, Scaldaferri, F, Pugliese, D, Savarino, E, Bodini, G, Cuomo, A, Donnarumma, L, Maconi, G, Cataletti, G, Rodino, S, Sebkova, L, Ferronato, A, Gaiani, F, Marzo, M, Luppino, I, Paese, P, Elisei, W, Monterubbianesi, R, Faggiani, R, Napolitano, D, Grossi, L, Serio, M, Scarcelli, A, Lorenzetti, R, Allegretta, L, Rocco, G, Zampaletta, C, Bolognini, L, Meucci, C, Colucci, R, Tonti, P, Della Valle, N, Piga, R, Forti, G, Onidi, F M, Usai Satta, P, Picchio, M, Papa, A, Tursi, A

“…Abstract Background Ustekinumab (UST) is an interleukin-12/interleukin-23 receptor antagonist recently approved for treating ulcerative colitis (UC), but with…”
Get full text

T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY by Mocci, G., Maconi, G., Cataletti, G., Mantia, B., Serio, M., Scarcelli, A., Onidi, F.M., Pagnini, C., Graziani, M., Di Paolo, M., Pranzo, G., Luppino, I., Paese, P., Monterubbianesi, R., Faggiani, R., Ferronato, A., Perini, B., Savarino, E., Binaghi, L., Schiavoni, E., Napolitano, D., Scaldaferri, F., Papa, A., Lorenzetti, R., Pica, R., Cocco, A., Rodino, S., Sebkova, L., Zampaletta, C., Gaiani, F., Fanigliulo, L., Allegretta, L., Cuomo, A., Donnarumma, L., Della Valle, N., Forti, G., Dore, M., Antonelli, E., Bassotti, G., Iannelli, C., Aragona, G., Lauria, A., Piergallini, S., Colucci, R., Meucci, C., Usai Satta, P., Elisai, W., Tursi, A.

Get full text

P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn’s disease: results from “long vedo” italian multicenter study by Mocci, G, Maconi, G, Onidi, F M, Cataletti, G, Elisei, W, Scaldaferri, F, Lorenzetti, R, Pagnini, C, Scarcelli, A, Graziani, M G, Di Paolo, M C, Pranzo, G, Luppino, I, Monterubbianesi, R, Faggiani, R, Ferronato, A, Savarino, E, Pica, R, Cocco, A, Rodino, S, Sebkova, L, Zampaletta, C, Gaiani, F, Fanigliulo, L, Allegretta, L, Cuomo, A, Donnarumma, L, Della Valle, N, Forti, G, Antonelli, E, Bassotti, G, Iannelli, C, Aragona, G, Lauria, A, Piergallini, S, Colucci, R, Binaghi, L, Meucci, C, Papa, A, Tursi, A

“…Abstract Background Current data about long-term use of vedolizumab (VDZ) in ulcerative colitis (UC) versus Crohn’s disease (CD) patients are limited. We aimed…”
Get full text

P.06.14 EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY by Tursi, A., Franceschi, M., Allegretta, L., Savarino, E., De Bastiani, R., Elisei, W., Baldassarre, G., Ferronato, A., Penna, A., Licci, C., Rizzo, G.L., Pranzo, G., Cassieri, C., Brandimarte, G., Picchio, M., Scida, S., Miraglia, C., Di Mario, F.

Get full text

P.07.14 INTER-OBSERVER AGREEMENT OF ULCERATIVE COLITIS “EXTENDED MAYO ENDOSCOPIC SCORE (EMES)” WITHIN A MULTICENTER INFLAMMATORY BOWEL DISEASE (IBD) TEAM WORK by Contaldo, A., Bianchi, F.P., Losurdo, G., Iannone, A., Albano, F., Allegretta, L., Bossa, F., De Tullio, N., Valle, N. Della, Fiorella, S., Hadad, Y., Mazzuoli, S., Paiano, P., Rispo, A., Stasi, E., Tursi, A., Ierardi, E., Tafuri, S., Principi, M., Di Leo, A.

Get full text

P583 Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: results from a large Italian cohort study by Mocci, G, Cuomo, A, Allegretta, L, Aragona, G, Colucci, R, Della Valle, N, Ferronato, A, Forti, G, Gaiani, F, Graziani, M G, Lorenzetti, R, Luzza, F, Penna, A, Pica, R, Piergallini, S, Rodinò, S, Scarcelli, A, Zampaletta, C, Cicerone, C, Cocco, A, De Angelis, G, Donnarumma, L, Pranzo, G, Franceschi, M, Gallina, S, Grasso, G, Larussa, T, Luppino, I, Faggiani, R, Fanigliulo, L, Pagnini, C, Perazzo, P, Sacco, R, Sebkova, L, Serio, M E, De Monti, A, Picchio, M, Elisei, W, Maconi, G, Tursi, A

“…Abstract Background Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn’s Disease (CD). The aim of this study was to compare the efficacy…”
Get full text

P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY by Tursi, A., Brandimarte, G., Di Mario, F., Elisei, W., Picchio, M., Allegretta, L., Annunziata, M.L., Astegiano, M., Bafutto, M., Baldi, F., Bassotti, G., Bianco, M.A., Colucci, R., Conigliaro, R., Danese, S., Dumitrascu, D.L., Escalante, R., Faggiani, R., Fiorella, S., Forti, G., Franceschi, M., Giorgetti, G., Grad, S., Graziani, M.G., Lai, M.A., Lammert, F., Latella, G., Lisi, D., Maconi, G., Murphy, M.M., Nardone, G., De Oliveira, L. Camara, De Oliveira, E. Chaves, Papa, A., Papagrigoriadis, S., Penna, A., Pietrzak, A., Pontone, S., Portincasa, P., Poskus, T., Pranzo, G., Reichert, M., Rizzo, G.L., Rodinò, S., Regula, J., Scaccianoce, G., Scaldaferri, F., Schiffino, L., Stundiene, I., Vassallo, R., Walker, M., Zampaletta, C., Zullo, A.

Get full text

OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS by Tursi, A., Brandimarte, G., Di Mario, F., Nardone, G., Scarpignato, C., Picchio, M., Elisei, W., Allegretta, L., Annunziata, M.L., Astegiano, M., Baldi, F., Bassotti, G., Bianco, M.A., Cambiè, G., Capezzuto, E., Caroli, A., Cassieri, C., Cicu, A.S., Ciliberto, E., Colucci, R., Conigliaro, R., Damiani, A., De Colibus, P., De Medici, A., De Pretis, G., Favero, G. Del, Valle, N. Della, Di Cesare, L., Faggiani, R., Febbraro, S., Ferrini, L., Fiorella, S., Forti, G., Franceschi, M., Frunzio, A., Germanà, B., Giorgetti, G., Giovannone, M., Graziani, M.G., Lai, M.A., Latella, G., Lisi, D., Lopetuso, L.R., Maconi, G., Mandelli, E.D., Marmo, R., Maurano, A., Pallotta, L., Papa, A., Parmeggiani, F., Penna, A., Pigò, F., Pontone, S., Pranzo, G., Ricciardelli, C., Rizzo, G.L., Rodinò, S., Savarino, E., Scaccianoce, G., Scaldaferri, F., Schiffino, L., Semeraro, C., Stroppa, I., Urgesi, R., Vassallo, R., Violi, A., Zampaletta, C., Lecca, P.G., Zilli, M., Zullo, A.

Get full text

P373 Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centres by Tursi, A., Allegretta, L., Della Valle, N., Elisei, W., Forti, G., Faggiani, R., Lorenzetti, R., Mocci, G., Penna, A., Pranzo, G., Paiano, P., Ricciardelli, C., Gallina, S., Picchio, M.

Get full text

Transferrin receptor expression in testis cancer by Petrylak, D P, Yagoda, A, O'Toole, K M, Chadburn, A, Sawczuk, I S, Benson, M C, Olsson, C A, Allegretta, L, Saad, A D, Wartinger, D D

Get more information

Studying the celiac disease by basic and PEG 4000 hydro-sonography by Allegretta, L., Giaccari, S., Tronei, S., Chiri, S., Grasso, G.

Get full text

8 OC Are numerous colonscopy a risk factor for patients suffering from I.B.D. regarding HBV and HCV infections? by Giaccari, S., Allegretta, L., Tronci, S., Chiri, S., Grasso, G.

Get full text

Gastrospirillum Hominis associated chronic active gastritis: the first report from Italy by Ierardi, E, Monno, R, Mongelli, A, Allegretta, L, Milone, E, Rizzi, S, Panza, P, Coppolecchia, P, Francavilla, A

“…Recently a spiral bacterium different from Helicobacter Pylori (HP) was observed in the human stomach and the name of Gastrospirillum Hominis (GH) was proposed…”
Get more information

Crohn's disease fistulas: An unusual clinical appearance by Allegretta, L., Giaccari, S., Tronci, S., Chiri, S., Grasso, G., Sponziello, G.

Get full text

Oral S. typhi vaccination and crohns disease appearance: It was a trigger? by Allegretta, L., Giaccari, S., Tronci, S., Chiri, S., Grasso, G., Sponziello, G.

Get full text

Use of infliximab in healing rectovaginal Crohn's disease fistulas: Two cases study by Allegretta, L., Giaccari, S., Tronci, S., Chiri, S., Grasso, G., Sponziello, G.

Get full text

Partially hydrolyzed guar gum: a fiber as coadjuvant in the irritable colon syndrome by Giaccari, S, Grasso, G, Tronci, S, Allegretta, L, Sponziello, G, Montefusco, A, Siciliano, I G, Guarisco, R, Candiani, C, Chiri, S

“…Partially hydrolyzed guar gum (PHGG) is a water-soluble dietary fiber, possessing non-gelling properties. The objective of this clinical experience was to…”
Get more information